Related Experiment Video

Updated: Aug 5, 2026

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
07:19

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

Published on: October 21, 2010

Overview: antifungal combination therapy

A M Sugar1

  • 1Boston Medical Center, MA 02118, USA. asugar@medicine.bumc.bu.edu

Current Opinion in Investigational Drugs (London, England : 2000)
|March 14, 2002
PubMed

Insights

Combination antifungal therapy shows potential but requires careful study. Future research must define drug interactions and optimal experimental designs for treating fungal infections, guiding cautious clinical use.

Area of Science:

  • Mycology
  • Pharmacology
  • Clinical Medicine

Background:

  • The clinical efficacy of combination antifungal therapy remains largely unrealized.
  • Emerging literature highlights both potential benefits and drawbacks of using multiple antifungal agents concurrently.
  • Understanding drug interactions is crucial for optimizing antifungal treatment strategies.

Purpose of the Study:

  • To review the current understanding of combination antifungal therapy.
  • To emphasize the need for rigorous laboratory studies to elucidate drug interactions.
  • To discuss the challenges in designing appropriate experimental models for evaluating combination antifungal efficacy in human mycoses.

Main Methods:

  • Literature review of existing studies on combination antifungal therapy.
  • Analysis of reported positive and negative aspects of combined drug use.
  • Discussion of experimental design considerations for future research.

Main Results:

  • The full clinical benefits of combination antifungal therapy are not yet established.
  • Laboratory studies are essential to define interactions between different antifungal compounds.
  • Appropriate experimental designs are needed to accurately reflect outcomes in treating human fungal infections.

Conclusions:

  • Combination antifungal therapy requires a cautious, case-by-case approach.
  • Further research is necessary to establish optimal protocols and predict clinical outcomes.
  • Defining the best experimental parameters for studying combination antifungal therapy is a key challenge for the coming years.

More Related Videos

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...